MAOA and Alzheimer disease: Based on our results and others, we suggest that the alteration of regional MAO-A/B activities following Aβ 1-42 infusion may involve the regional activation of astrocytes around plaques sites and the loss of astrocytes/neurons with the progress of AD [27,31].